BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Influenza
,
Lung
,
Laryngoscope
,
Prozac
,
rs2300478
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PALB2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Dendritic (plasmacytoid) cell
Penis
Peritoneum
T Lymphocyte (regulatory) of peripheral blood
Endometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Platelet count below reference range
Platelet disorder
Caseating tuberculoid granuloma
Blood coagulation disorder
Anemia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Strophanthidin
Digoxigenin
lanatoside C
Proscillaridin
corchoroside A
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR98
PALB2
CLOCK
CHUK
DBI
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia …
Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates wit…
Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in H…
Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2.
A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers
Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metasta…
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Defic…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ